News > Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy’s to shut plants

Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy’s to shut plants

In a major data breach, drug maker Dr Reddy's Laboratories has temporarily shut down production across its key plants. This comes just days after the company received an approval from DCGI to conduct phase 2 and 3 trials for a reworked protocol that sought some additional information.

The company is currently reviewing its IT network systems. It's still not known at this point how much time it would take to resume production.

-